Pan, David Z.
Miao, Zong
Comenho, Caroline
Rajkumar, Sandhya
Koka, Amogha
Lee, Seung Hyuk T.
Alvarez, Marcus
Kaminska, Dorota
Ko, Arthur
Sinsheimer, Janet S.
Mohlke, Karen L.
Mancuso, Nicholas
Muñoz-Hernandez, Linda Liliana
Herrera-Hernandez, Miguel
Tusié-Luna, Maria Teresa
Aguilar-Salinas, Carlos
Pietiläinen, Kirsi H.
Pihlajamäki, Jussi
Laakso, Markku
Garske, Kristina M.
Pajukanta, Päivi http://orcid.org/0000-0002-6423-8056
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL-095056, HL-28481, F31-HL142180)
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK105561, F31 DK118865-02, DK072193, DK093757, DK062370)
National Cancer Institute (T32LM012424)
American Heart Association (19PRE34430112)
National Institute of General Medical Sciences (R25GM055052, GM-0532275)
Howard Hughes Medical Institute (Gilliam Fellowhip)
National Human Genome Research Institute (HG-009120, Z01HG000024)
Academy of Finland (316458, 138006)
Article History
Received: 3 September 2020
Accepted: 14 July 2021
First Online: 2 August 2021
Change Date: 30 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13073-021-00954-3
Declarations
:
: All participants provided informed written consent to participate in the studies. The METSIM and KOBS studies were approved by the Ethics Committee of the Kuopio University Central Hospital; the Finnish Twin and CRYO studies were approved by the Ethics Committee of the Helsinki University Central Hospital; and the MOSS study was approved by the Ethics Committee of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The research was performed in accordance with the principles of the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.